Children's Hospital Colorado

Neuroscience Research

The logo for the Advancing Treatment for Pediatric Craniopharyngioma Consortium
Research article

Advancing Treatment for Pediatric Craniopharyngioma (ATPC) is North America’s first multicenter consortium dedicated exclusively to the discovery and testing of novel therapies for children with adamantinomatous craniopharyngioma (ACP).


At Children's Hospital Colorado, we're constantly striving to push the boundaries of neuro-oncology research. Learn more in the video below: 

What our research means for kids

The Neuroscience Institute (NSI) at Children’s Hospital Colorado is dedicated to advancing research to discover the best ways to treat, diagnose and cure children with neurological and neurodevelopmental disorders.  

Our doctors and scientists are internationally recognized leaders, making Children’s Colorado one of the leading pediatric research institutes in the world. Our team works together in basic, translational and clinical research supported by more than $3 million per year in grant and philanthropic funding.

Through these innovative studies, we are able to improve treatment options and results not only for our patients, but for children around the world.  

Make a gift to support research

A gift to Neuroscience Institute research helps us discover new treatments and cures for children with neurological and neurodevelopmental disorders.  

Your generosity allows us to support research by outstanding investigators – all leading to improved quality of life for kids. Donate today.

Learn more about the Neuroscience Institute.